Skip to main content

Clifford Chance

Clifford Chance
All
Robert Chung

Robert Chung

Partner

Partner
Robert Chung

Robert Chung is a Corporate M&A partner in New York. He advises corporations, boards of directors, special committees, financial sponsors and other stakeholders on a wide range of complex domestic and cross-border M&A transactions. Robert also regularly represents investment banking firms in their role as financial advisors in M&A transactions.

Robert's practice focuses on deal execution and optimized efficiency for clients across a range of industry sectors, including energy, infrastructure, media, technology, healthcare, life sciences, insurance and retail.

  • Iberdrola, S.A. in its acquisition of 100% of Avangrid, Inc.
  • NRG Energy, Inc. (NYSE: NRG) in its acquisition of Vivint Smart Home, Inc. and NRG Energy, Inc. in activism defense matters.
  • Macquarie Infrastructure Corp. (NYSE: MIC) and its related entities in the sale of three businesses, including the sale of its Atlantic Aviation business to KKR and its MIC Hawaii business to Argo Infrastructure Partners, LP.
  • Brookfield Infrastructure Partners in its bid to acquire Inter Pipeline Ltd.
  • Golden Nugget Online Gaming, Inc. (NASDAQ: GNOG) and the Special Committee of its Board of Directors in GNOG’s sale to DraftKings Inc.
  • ION Acquisition Corp 1 Ltd. (NYSE: IACA), a SPAC, in its business combination with Taboola.com Ltd.
  • ION Acquisition Corp 2 Ltd. (NYSE: IACB), a SPAC, in its business combination with Innovid, Inc.
  • The Special Committee of Cellular Biomedicine Group, Inc. in its sale to a consortium including certain members of CBMG management, CBMG stockholders and financial sponsors.
  • Alberta Investment Management Corporation (Aimco), in a joint venture with The AES Corporation (NYSE: AES).
  • A consortium composed of Brookfield Infrastructure, its institutional partners and GIC, Singapore's sovereign wealth fund, on its acquisition of Genesee & Wyoming Inc. (NYSE:GWR).
  • LifePoint Health, Inc. (NASDAQ: LPNT) in its sale to RCCH HealthCare Partners, which is owned by certain funds managed by affiliates of Apollo Global Management, LLC.
  • SodaStream International Ltd. (NASDAQ/TLV: SODA) in its sale to PepsiCo, Inc..
  • Luxoft Holding, Inc. (NYSE: LXFT) in its sale to DXC Technology.
  • Roark Capital Group and its portfolio company Arby's Restaurant Group, in Arby's acquisition of Buffalo Wild Wings, Inc..
  • Inspire Brands, Inc., a portfolio company of Roark Capital Group, in its acquisition of Sonic Corp.
  • Roark Capital Group and Inspire Brands, Inc. in the acquisition of Jimmy John's LLC.  
  • Calpine Corporation (NYSE: CPN) in its sale to Energy Capital Partners and a consortium of investors including Access Industries and Canadian Pension Plan Investment Board.
  • PPF Group N.V. in its acquisition of Central European Media Enterprises Ltd.
  • Zimmer Holding's, Inc. (NYSE and SIX: ZBH) in its acquisition of LVB Acquisition, Inc.
  • Zimmer Biomet (NYSE and SIX: ZBH) in its acquisition of LDR Holding Corporation.
  • Omnicare, Inc. in its sale to CVS Health Corporation.
  • Illumina, Inc. in its defense against Roche Holding Ltd.'s unsolicited cash tender offer and proxy contest.
  • Omnicare, Inc. in its unsolicited cash tender offer for PharMerica Corporation.
  • Sony/ATV and EMI Music Publishing in the sale of selected music catalogs, including catalogs owned by Virgin Music Publishing Companies and Famous UK Music Publishing, to BMG, the world's fourth-largest music publishing company.
  • MetLife, Inc. in its acquisition of American Life Insurance Company and certain subsequent divestitures of businesses of American Life Insurance Company.
  • Alimentation Couche-Tard Inc. in its unsolicited cash tender offer for Casey's General Stores, Inc.
  • Nordic Capital, DLJ Merchant Banking, Avista Capital and other private equity sponsors in their sale of Fougera Pharmaceuticals to Sandoz.
  • Fisher Communications, Inc. in its sale to Sinclair Broadcast Group, Inc.
  • The Talbots, Inc. in its sale to Sycamore Partners, and in its sale of the J. Jill business to Golden Gate Capital.
  • King Pharmaceuticals, Inc. in its unsolicited acquisition of Alpharma Inc.

News and client work

View all news and client work featuring Robert Chung

Contact details

Career and qualifications

  • Brown University (BA, Business Economics) 1997
  • Northwestern University Pritzker School of Law (JD) 2000
  • Admitted as Attorney-at Law in California 2000
  • Admitted as Attorney-at Law in Washington, DC 2009
  • Admitted as Attorney-at Law in New York 2009
  • Joined Clifford Chance as partner 2025

Awards and citations

  • Leading Individual for M&A in the United States, Euromoney, 2021

    Toolkits & Client Log-in